DK2694538T3 - Terapeutiske og profylaktiske fremgangsmåder, anvendelser og sammensætninger omfattende anexin a5 - Google Patents
Terapeutiske og profylaktiske fremgangsmåder, anvendelser og sammensætninger omfattende anexin a5Info
- Publication number
- DK2694538T3 DK2694538T3 DK12713969.9T DK12713969T DK2694538T3 DK 2694538 T3 DK2694538 T3 DK 2694538T3 DK 12713969 T DK12713969 T DK 12713969T DK 2694538 T3 DK2694538 T3 DK 2694538T3
- Authority
- DK
- Denmark
- Prior art keywords
- anexin
- therapeutic
- applications
- prophylactic procedures
- comprehensive
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system having sulfur as a ring hetero atom, e.g. ticlopidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
- A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/49—Urokinase; Tissue plasminogen activator
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4728—Calcium binding proteins, e.g. calmodulin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Marine Sciences & Fisheries (AREA)
- Toxicology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161472013P | 2011-04-05 | 2011-04-05 | |
US201161472002P | 2011-04-05 | 2011-04-05 | |
PCT/EP2012/056370 WO2012136819A1 (en) | 2011-04-05 | 2012-04-05 | Therapeutic and prophylactic methods, uses and compositions comprising anexin a5 |
Publications (1)
Publication Number | Publication Date |
---|---|
DK2694538T3 true DK2694538T3 (da) | 2017-01-02 |
Family
ID=45953134
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK12713969.9T DK2694538T3 (da) | 2011-04-05 | 2012-04-05 | Terapeutiske og profylaktiske fremgangsmåder, anvendelser og sammensætninger omfattende anexin a5 |
Country Status (7)
Country | Link |
---|---|
US (3) | US20140037614A1 (da) |
EP (1) | EP2694538B1 (da) |
DK (1) | DK2694538T3 (da) |
ES (1) | ES2607066T3 (da) |
HU (1) | HUE030922T2 (da) |
PL (1) | PL2694538T3 (da) |
WO (1) | WO2012136819A1 (da) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10987313B2 (en) | 2013-10-07 | 2021-04-27 | Impax Laboratories, Llc | Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof |
EP3054929B1 (en) | 2013-10-07 | 2020-08-05 | Impax Laboratories, LLC | Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof |
GB2542391A (en) | 2015-09-17 | 2017-03-22 | Annexin Pharmaceuticals Ab | Process of manufacture |
GB201702144D0 (en) | 2017-02-09 | 2017-03-29 | Annexin Pharmaceuticals Ab | Therapeutic compositions |
US11357823B2 (en) * | 2019-08-30 | 2022-06-14 | Suzhou Yabao Pharmaceutical R&D Co., Ltd | Method for treating cerebral stroke |
US11986449B2 (en) | 2020-12-22 | 2024-05-21 | Amneal Pharmaceuticals Llc | Levodopa dosing regimen |
CN115245559A (zh) * | 2021-04-25 | 2022-10-28 | 上海萨美细胞技术有限公司 | 一种用于治疗肺损伤的药物 |
EP4355765A2 (en) | 2021-06-14 | 2024-04-24 | Institut National de la Santé et de la Recherche Médicale (INSERM) | Mutated annexin a5 polypeptides and uses thereof for therapeutic purposes |
CA3189560A1 (en) * | 2022-03-04 | 2023-09-04 | Suzhou Yabao Pharmaceutical R&D Co., Ltd. | Methods of treating a traumatic brain injury |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE359807T1 (de) | 2001-02-21 | 2007-05-15 | Surromed Inc | Modifizierte annexin-proteine und verhinderung und behandlung von thrombose |
US7635676B2 (en) * | 2001-02-21 | 2009-12-22 | Alavita Pharmaccuticals, Inc. | Modified annexin proteins and methods for their use in organ transplantation |
PL1755642T3 (pl) | 2004-04-15 | 2010-06-30 | Athera Biotechnologies Ab | Aneksyna V do zapobiegania pękaniu blaszek miażdżycowych |
US8809497B2 (en) | 2007-12-18 | 2014-08-19 | Annexin Pharmaceuticals Ab | Compounds and methods for the treatment of vascular disease |
HUE044621T2 (hu) | 2008-02-22 | 2019-11-28 | Annexin Pharmaceuticals Ab | Vegyületek és eljárások resztenózis megelõzésére vagy kezelésére |
-
2012
- 2012-04-05 EP EP12713969.9A patent/EP2694538B1/en active Active
- 2012-04-05 ES ES12713969.9T patent/ES2607066T3/es active Active
- 2012-04-05 PL PL12713969T patent/PL2694538T3/pl unknown
- 2012-04-05 US US14/110,176 patent/US20140037614A1/en not_active Abandoned
- 2012-04-05 DK DK12713969.9T patent/DK2694538T3/da active
- 2012-04-05 WO PCT/EP2012/056370 patent/WO2012136819A1/en active Application Filing
- 2012-04-05 HU HUE12713969A patent/HUE030922T2/en unknown
-
2017
- 2017-05-26 US US15/606,623 patent/US20180015142A1/en not_active Abandoned
-
2019
- 2019-10-17 US US16/656,234 patent/US20200179484A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
US20140037614A1 (en) | 2014-02-06 |
EP2694538A1 (en) | 2014-02-12 |
US20180015142A1 (en) | 2018-01-18 |
HUE030922T2 (en) | 2017-06-28 |
ES2607066T3 (es) | 2017-03-29 |
EP2694538B1 (en) | 2016-09-14 |
PL2694538T3 (pl) | 2017-04-28 |
US20200179484A1 (en) | 2020-06-11 |
WO2012136819A1 (en) | 2012-10-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL250824A0 (en) | Certain amino-pyrimidines, their assemblies, and methods of using them | |
DK3597644T3 (da) | Kationiske aminlipider og anvendelser deraf | |
DK2694538T3 (da) | Terapeutiske og profylaktiske fremgangsmåder, anvendelser og sammensætninger omfattende anexin a5 | |
DK2729151T3 (da) | Farmaceutisk sammensætning, fremgangsmåder til behandling og anvendelser deraf | |
DK2872153T3 (da) | Accellulære pro-tolerogene sammensætninger og fremgangsmåde til fremstilling heraf | |
DK3415157T3 (da) | N-acyldipeptidderivater og anvendelser deraf | |
BR112014010290A2 (pt) | composição farmacêutica, métodos, composições e usos | |
EP2884984A4 (en) | THERAPEUTIC COMPOSITIONS AND METHOD | |
ES2969034T3 (es) | Composiciones bacteriófagas terapéuticas | |
DK2917181T3 (da) | Heteroarylderivater og anvendelser deraf | |
EP2895181A4 (en) | TOPICAL COMPOSITIONS AND METHODS OF USE | |
GB201113770D0 (en) | Novel compositions and uses thereof | |
DK2745849T3 (da) | Polydeoxyribonukleotidsammensætning og anvendelser deraf | |
GB2501611B (en) | Alpha-2-macroglobulin compositions and therapeutic uses | |
HK1207824A1 (en) | Polymorph compositions, methods of making, and uses thereof | |
DK2704744T3 (da) | Komplementfaktor-b-analoger og anvendelser deraf | |
DK3210990T3 (da) | Levoisovalerylspiramycin iii og præparater, fremstillingsfremgangsmåder og anvendelser deraf | |
DK2854822T3 (da) | Polysaccharidsammensætninger og fremgangsmåder til anvendelse | |
BR112014020677A2 (pt) | composições de farinha de milho e métodos de produção | |
DK2661274T3 (da) | Sammensætninger og fremgangsmåder med aloepolysaccharider | |
DK2877736T3 (da) | Skrue, skruedel og fremgangsmåde dertil | |
DK2849798T3 (da) | Oligonukleotid-chelatkompleks-polypeptidsammensætninger og fremgangsmåder | |
EP2609189A4 (en) | METHODS, DEVICES AND USES RELATED TO BIOFILMS | |
DK3156060T3 (da) | Farmaceutiske sammensætninger og topisk anvendelse deraf | |
HK1200392A1 (en) | Acetaminophen conjugates, compositions and methods of use thereof |